Back to search

Article

A missense mutation (C667F) in β-dystroglycan results in reduced dystroglycan protein levels leading to myopathy and destabilization of the blood-brain and blood-retinal barrier protein network

2023-11-13

Abstract excerpt

Dystroglycan (DG) is a glycoprotein and extracellular matrix receptor consisting of an α-DG and a β-DG subunit encoded by the gene DAG1 . A homozygous missense mutation (c.2006G>T), resulting in an amino acid substitution (p.Cys669Phe) in the extracellular domain of β-DG, causes severe Muscle-Eye-Brain disease with multicystic leukodystrophy. To investigate the mechanisms underlying the severe human pathology, we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cbb5d5a9-9bac-5b3c-8789-b2ff284fd22d
DOI
10.1101/2023.11.10.566559
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A missense mutation (C667F) in β-dystroglycan results in reduced dystroglycan protein levels leading to myopathy and destabilization of the blood-brain and blood-retinal barrier protein networkDOI 10.1101/2023.11.10.566559
Select a neighboring publication to make it the new centre.